Study: Treatment-resistant childhood leukemia tied to gene

01/12/2009 | Yahoo!

Dutch and German researchers found that children with a subtype of acute lymphoblastic leukemia who have the BCR-ABL1 fusion gene are more prone to relapse than patients without the gene. The finding suggests that carriers of the gene should get more intensive treatment with medicines already on the market "or with new, more-targeted drugs for which the biology of the BCR-ABL1-like subtype needs further study," the lead scientist said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC